Search Results

Press Releases

Roche transforms mass spectrometry diagnostics with launch of cobas® Mass Spec solution

December 18, 2024

·

4 min read

Roche Partners With COUR in Autoimmune Deal Potentially Worth More Than $900M

The collaboration will see COUR and Roche’s Genentech leverage the biotech’s antigen-specific immune tolerance platform to develop and commercialize therapies for an undisclosed autoimmune disease.

December 3, 2024

·

1 min read

·

Heather McKenzie

Antibody drug conjugate

Roche Kicks Off 2025 Committing a Potential $1B for Another ADC From China

Roche has once again returned to China to bolster its antibody-drug conjugate pipeline, this time striking a licensing deal with Innovent for $1 billion in biobucks.

January 2, 2025

·

2 min read

·

Annalee Armstrong

Policy

Roche receives FDA clearance on its digital pathology solution for diagnostic use

Roche announced that its whole-slide imaging system, the Roche Digital Pathology Dx, has received 510 clearance from the United States Food and Drug Administration.

June 18, 2024

·

3 min read

Mergers & acquisitions

Roche Buys Poseida for up to $1.5B, Leaning Into Off-the-Shelf CAR T

The acquisition announcement came alongside the reveal of a Phase III failure for Roche’s TIGIT asset tiragolumab, which when combined with Tecentriq did not significantly boost overall survival in non-small cell lung cancer.

November 26, 2024

·

3 min read

·

Tristan Manalac

Weight loss

Roche’s Obesity Pill Candidate Hit With Safety Concerns Despite Strong Efficacy Data

When doses were increased rapidly in a Phase I study, patients on Roche’s investigational oral GLP-1 receptor agonist experienced nausea, vomiting, constipation, diarrhea, as well as abdominal distension.

September 12, 2024

·

2 min read

·

Tristan Manalac

Business

Roche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing

Roche announced that Hitachi High-Tech and Roche have extended their partnership, committing to at least 10 years of additional collaboration.

May 27, 2024

·

5 min read

Press Releases

Roche receives FDA approval for first companion diagnostic to identify patients with biliary tract cancer eligible for HER2-targeted treatment with ZIIHERA

November 25, 2024

·

6 min read

Press Releases

Roche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer’s disease

October 31, 2024

·

8 min read

Earnings

Roche Beats Q3 Sales Estimates as CEO Voices Opposition to Novo Holdings’ Catalent Buyout

Jefferies analyst Peter Welford noted that Roche’s pharma group came just slightly ahead of consensus expectations, driven by strong performance of its multiple sclerosis therapy Ocrevus and eye injection Vabysmo.

October 23, 2024

·

3 min read

·

Tristan Manalac